View in EDS

Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.

Saved in:
Bibliographic Details
Title: Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.
Authors: Perry WL 3rd; Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285, USA. bperry@lilly.com, Shepard RL, Sampath J, Yaden B, Chin WW, Iversen PW, Jin S, Lesoon A, O'Brien KA, Peek VL, Rolfe M, Shyjan A, Tighe M, Williamson M, Krishnan V, Moore RE, Dantzig AH
Source: Cancer research [Cancer Res] 2005 Aug 01; Vol. 65 (15), pp. 6593-600.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 16061639
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Perry+WL+3rd%22">Perry WL 3rd</searchLink>; Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285, USA. bperry@lilly.com<br /><searchLink fieldCode="AU" term="%22Shepard+RL%22">Shepard RL</searchLink><br /><searchLink fieldCode="AU" term="%22Sampath+J%22">Sampath J</searchLink><br /><searchLink fieldCode="AU" term="%22Yaden+B%22">Yaden B</searchLink><br /><searchLink fieldCode="AU" term="%22Chin+WW%22">Chin WW</searchLink><br /><searchLink fieldCode="AU" term="%22Iversen+PW%22">Iversen PW</searchLink><br /><searchLink fieldCode="AU" term="%22Jin+S%22">Jin S</searchLink><br /><searchLink fieldCode="AU" term="%22Lesoon+A%22">Lesoon A</searchLink><br /><searchLink fieldCode="AU" term="%22O'Brien+KA%22">O'Brien KA</searchLink><br /><searchLink fieldCode="AU" term="%22Peek+VL%22">Peek VL</searchLink><br /><searchLink fieldCode="AU" term="%22Rolfe+M%22">Rolfe M</searchLink><br /><searchLink fieldCode="AU" term="%22Shyjan+A%22">Shyjan A</searchLink><br /><searchLink fieldCode="AU" term="%22Tighe+M%22">Tighe M</searchLink><br /><searchLink fieldCode="AU" term="%22Williamson+M%22">Williamson M</searchLink><br /><searchLink fieldCode="AU" term="%22Krishnan+V%22">Krishnan V</searchLink><br /><searchLink fieldCode="AU" term="%22Moore+RE%22">Moore RE</searchLink><br /><searchLink fieldCode="AU" term="%22Dantzig+AH%22">Dantzig AH</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2005 Aug 01; Vol. 65 (15), pp. 6593-600.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0008-5472 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=16061639
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/0008-5472.CAN-03-3675
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6593
    Titles:
      – TitleFull: Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Perry WL 3rd
      – PersonEntity:
          Name:
            NameFull: Shepard RL
      – PersonEntity:
          Name:
            NameFull: Sampath J
      – PersonEntity:
          Name:
            NameFull: Yaden B
      – PersonEntity:
          Name:
            NameFull: Chin WW
      – PersonEntity:
          Name:
            NameFull: Iversen PW
      – PersonEntity:
          Name:
            NameFull: Jin S
      – PersonEntity:
          Name:
            NameFull: Lesoon A
      – PersonEntity:
          Name:
            NameFull: O'Brien KA
      – PersonEntity:
          Name:
            NameFull: Peek VL
      – PersonEntity:
          Name:
            NameFull: Rolfe M
      – PersonEntity:
          Name:
            NameFull: Shyjan A
      – PersonEntity:
          Name:
            NameFull: Tighe M
      – PersonEntity:
          Name:
            NameFull: Williamson M
      – PersonEntity:
          Name:
            NameFull: Krishnan V
      – PersonEntity:
          Name:
            NameFull: Moore RE
      – PersonEntity:
          Name:
            NameFull: Dantzig AH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2005 Aug 01
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 0008-5472
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 15
          Titles:
            – TitleFull: Cancer research
              Type: main
ResultId 1